-
今开：--
昨收：--
-
今日区间：--
52周区间：--
-
成交量：--
成交额：--
-
市 值：--
市盈率：--
-
振幅：
每股收益：
成交量
董事会
- Carrie Smith Cox
- Carrie Smith Cox currently serves as Executive Chairman at Organon & Co. starting in 2025, Chairman at Solventum Corp. since 2024, Independent Director at Texas Instruments Incorporated since 2004, and Member of the Overseers Board at the University of Pennsylvania Museum of Archaeology & Anthropology. Former roles include Chairman at Array BioPharma, Inc. (2018-2019), Chairman at Prism Pharmaceuticals, Inc., Executive Chairman at Humacyte Global, Inc. (2018-2019), Chairman at electroCore, Inc. (2018-2020), Chairman at Candel Therapeutics, Inc. (2021), Chairman at Cartesian Therapeutics, Inc. (2023-2025), Chairman at Selecta Biosciences, Inc. (2019-2023), Independent Director at Cardinal Health, Inc. (2011-2023), Independent Director at Celgene Corp. (2011-2019), Director at Renetx Bio, Inc., Director at Humacyte, Inc. (2019-2021), Executive Vice President at Pharmacia & Upjohn, Inc. (1997-2012), President-Global Pharmaceuticals & Executive Vice President at Schering-Plough Corp. (2003-2009), Principal at Novartis Corp., President-Global Pharmaceutical Business & Executive Vice President at Pharmacia Corp. (1997-2003), Vice President-Women's Healthcare at Wyeth-Ayerst Research, and Member at Harvard T.H. Chan School of Public Health. Education includes an undergraduate degree from Massachusetts College of Pharmacy & Health Science conferred in 1981.
-
- Robert A. Essner
- Robert A. Essner is currently the Chairman at Elucida Oncology, Inc., the Director at The Children's Health Fund, the Director at Elorac, Inc., the Independent Director at Organon & Co., the Trustee at Lincoln Center for the Performing Arts, Inc., and the Trustee at Mote Marine Laboratory, Inc. Previously, Mr. Essner served as the Chief Executive Officer at Fort Dodge Animal Health, Inc., the Chairman, President & Chief Executive Officer at Wyeth Pharmaceuticals, Inc., the Chairman at Wyeth LLC, and the Chairman at Pharmaceutical Research & Manufacturers of America. He also held positions such as Lead Director at Massachusetts Mutual Life Insurance Co., Director at The Nature's Bounty Co. and Pharmaceutical Product Development LLC, Independent Director at Amicus Therapeutics, Inc., Director at Nissay Wealth Life Insurance KK and Alphabet Holding Co., Inc., and Director at MassMutual Financial Group (Connecticut). Additionally, he worked as a Senior Advisor at The Carlyle Group LP (Corporate Private Equity). Mr. Essner's education includes a graduate degree from The University of Chicago and an undergraduate degree from Miami University.
-
- R. Alan B. Ezekowitz
- R. Alan B. Ezekowitz is the founder of Azanta Danmark. AS (2000) and Abide Therapeutics, Inc. (2011) where the title held was Chief Executive Officer & Director. Current jobs include Director-Scientific Advisory Board at Codman Co., Inc., Independent Director at Fulcrum Therapeutics, Inc., Independent Director at Organon & Co., Director at Septerna, Inc., Venture Partner at CHP Management, Inc., and Member at American Society of Clinical Investigation. Former jobs include Chairman-Scientific Advisory Board at Anika Therapeutics, Inc., Non-Executive Director at Oxagen Ltd. (2013-2017), Director at The Children's Hospital Corp., Director-Scientific Advisory Board at Entomed SA, Director at Atopix Therapeutics Ltd., Director & Chief-Pediatric Services at Mass General Brigham, Inc. (2000-2006), Senior Vice President at Merck Research Laboratories Massachusetts LLC (2006-2011), Principal at The Massachusetts General Hospital, Principal at Alan Ezekowitz LLC (2011), Advisory Partner at Third Rock Ventures LLC (2019-2022), and Head-Developmental Immunology Laboratory at Harvard Medical School (1995-2006). Education includes a doctorate from the University of Oxford and a graduate degree from the University of Cape Town (1977).
-
- Ma. Fatima D. de Vera Francisco
- Ma. Fatima D. de Vera Francisco is an Independent Director at Organon & Co. She previously worked at Procter & Gamble Co. as the President-Global Baby Care, Baby & Feminine Care. She is an undergraduate from the University of the Philippines.
-
- Helene D. Gayle
- Helene D. Gayle is Chairman at the Federal Reserve Bank of Chicago, Chairman of The Presidential Advisory Council on HIV since 2009, Chairman of eMed LLC, Director at the University of Pennsylvania, Director at GoHealth LLC (Illinois), Director at The Economic Club of Chicago, Independent Director at Organon & Co. since 2021, Trustee at The Brookings Institution, Member of the Council on Foreign Relations, Inc., Member-Foreign Affairs Policy Board at the US Department of State (District of Columbia), Trustee at the Center for Strategic & International Studies, Inc. since 2007, Member of the American Academy of Arts & Sciences, Member of the National Academy of Medicine (United States), Member of the American Public Health Association, and Member of The Bretton Woods Committee. Former roles include President & Chief Executive Officer at CARE USA from 2006 to 2015, President & Chief Executive Officer at The Chicago Community Trust from 2017 to 2022, Chief Executive Officer at McKinsey.org from 2015 to 2017, Chairman at The New America Foundation, Director at Colgate-Palmolive Co. from 2010 to 2011, Director at Cox Enterprises, Inc., Program Director at Gates Foundation Trust from 2001 to 2006, Director-National Center for HIV, STD & TB at Centers for Disease Control & Prevention from 1995 to 2001, Director at Brentwood Press & Publishing Co., Director at The One Campaign, Independent Director at GoHealth, Inc. from 2020 to 2022, Independent Director at Palo Alto Networks, Inc. from 2021 to 2024, Independent Director at The Coca-Cola Co. from 2013 to 2024, President at Spelman College, Trustee at The American Museum of Natural History, and Trustee at The Rockefeller Foundation. Education includes a doctorate from the University of Pennsylvania, graduate studies at The Johns Hopkins University, and undergraduate studies at Barnard College.
-
- Rochelle B. Lazarus
- Rochelle B. Lazarus currently works at NewYork-Presbyterian Hospital, as Vice Chairman-Trustees Board from 1995, World Wildlife Fund, Inc., as Secretary & Director, The Partnership for New York City, Inc., as Director, Chief Executives For Corporate Purpose, Inc., as Director, Blackstone, Inc., as Independent Director from 2013, United States Defense Business Board, as Director, Organon & Co., as Independent Director from 2021, Council on Foreign Relations, Inc., as Member, The Business Council, as Member, The Committee of 200, as Member, Women's Forum, Inc., as Member, Advertising Women of New York, as Member, and Columbia Business School, as Member-Overseers Board. Ms. Lazarus also formerly worked at Ogilvy & Mather Worldwide, Inc., as Chairman from 2008 to 2012, Smith College, as Chairman, American Association of Advertising Agencies, Inc., as Chairman, Ann, Inc., as Director, GE Aerospace, as Independent Director from 2011 to 2018, Merck & Co., Inc., as Independent Director from 2004 to 2020, CMI Marketing, Inc., as Director, Lincoln Center for the Performing Arts, Inc., as Director, Blackstone Group Management LLC, as Director, Merck Sharp & Dohme Corp., as Director in 2009, Rockefeller Capital Management LP, as Director, Direct Marketing Association, Inc., as Member, The American Museum of Natural History, as Trustee, The Advertising Educationl Foundation, as Member, Financial Industry Regulatory Authority, Inc., as Member-Governors Board, Ogilvy & Mather Direct, as President-North America Region, and Ogilvy & Mather New York, as President. Ms. Lazarus received her Masters Business Admin degree from The Trustees of Columbia University in The City of New York and undergraduate degree in 1968 from Smith College.
-
- Deborah R. Leone
- Deborah R. Leone is currently a Director at Goldman Sachs Bank USA (New York), Ayco Charitable Foundation, and Goldman Sachs Philanthropy Fund. She is also an Independent Director at Organon & Co. and Corebridge Financial, Inc. Additionally, she serves as a Trustee at Syracuse University. Previously, she held the position of Chief Operating Officer at The Goldman Sachs Group, Inc. from 2017 to 2019. Ms. Leone completed her undergraduate degree and MBA at Syracuse University.
-
- Philip O. Ozuah
- Philip O. Ozuah currently works at Montefiore Medical Center, as President, Chief Executive Officer & Trustee, Montefiore Medicine Academic Health System, Inc., as President & Chief Executive Officer from 2019, Montefiore Einstein Comprehensive Cancer Center, as President & Chief Executive Officer, New York City Police Foundation, Inc., as Chairman, Federal Law Enforcement Foundation, as Director, Montefiore Hospital, as Director, The Cigna Group, as Independent Director from 2023, Organon & Co., as Independent Director from 2021, Albert Einstein College of Medicine, Inc., as Professor from 2014, and The New York Botanical Garden, as Trustee. Dr. Ozuah also formerly worked at Montefiore Health System, Inc., as President from 2018 to 2019. Dr. Ozuah received his doctorate degree from the University of Nebraska, graduate degree from the University of Southern California, and doctorate degree from the University of Ibadan.
-
- Cynthia M. Patton
- Cynthia M. Patton is currently the Director at Family Medical Center, The NALP Foundation for Law Career Research & Education, Martin Luther King Jr. General Hospital, Eisner Pediatric & Family Medical Center, Ethics & Compliance Initiative, and Martin Luther King, Jr. Community Hospital. She is also an Independent Director at Organon & Co. and a Trustee at Vassar College, National Association for Law Placement, Inc., and Wildwood School, Inc. In addition, she is the Secretary & General Counsel at Verily Life Sciences LLC. Previously, she was the Chairman at Amgen Foundation, Inc., Chief Compliance Officer & Senior Vice President at Amgen, Inc., Assistant General Counsel at Unihealth America, Inc., Principal at Alston & Bird LLP, General Counsel at SCAN Health Plan, Inc., and Secretary at Watts Healthcare Corp. She also served as the Secretary & General Counsel at Alphabet, Inc. Ms. Patton received her undergraduate degree from Vassar College in 1983 and her graduate degree from George Washington University Law School.
-
- Grace Puma Whiteford
- Ms. Grace P. Whiteford is an Independent Director at Phillips 66, an Independent Director at Target Corp. and an Independent Director at Organon & Co. She is on the Board of Directors at Phillips 66, Target Corp. and Organon & Co. Ms. Whiteford was previously employed as an Independent Director by Williams-Sonoma, Inc., a Chief Operations Officer & Executive VP by PepsiCo, Inc., a Global Chief Procurement Officer & Senior VP by United Continental Holdings, Inc., a Chief Procurement Officer & Senior Vice President by United Airlines, Inc., a Vice President by Kraft Foods, Inc., a Head-Strategic Supply Management by Gillette Co., and a Head-Strategic Supply Management by Motorola, Inc. She also served on the board at Marietta Corp., Institute for Supply Management and Steppenwolf Theatre Co. She received her undergraduate degree from Benedictine University.
-
- Shalini Sharp
- Shalini Sharp currently works at Mahzi Therapeutics, Inc., as Chairman, Neurocrine Biosciences, Inc., as Independent Director from 2020, Alameda County Community Food Bank, as Director, Organon & Co., as Independent Director from 2021, BeOne Medicines Ltd., as Independent Non-Executive Director from 2024, and Septerna, Inc., as Independent Director from 2024. Ms. Sharp also formerly worked at Elan Corp. Plc, as Chief Executive Officer from 2001 to 2003, Global Alliance for TB Drug Development, as Independent Director from 2015 to 2022, Agenus, Inc., as Independent Director from 2012 to 2018, Array BioPharma, Inc., as Independent Director from 2017 to 2019, Precision BioSciences, Inc., as Independent Director from 2018 to 2022, Sutro Biopharma, Inc., as Independent Director from 2018 to 2023, Mirati Therapeutics, Inc., as Independent Director from 2021 to 2024, Panacea Acquisition Corp., as Director from 2020 to 2021, Elan Pharmaceuticals LLC, as Chief of Staff from 1998 to 2003, Ultragenyx Pharmaceutical, Inc., as Chief Financial Officer & Senior VP-Finance from 2012 to 2020, and Dimension Therapeutics, Inc., as Treasurer & Vice President. Ms. Sharp received her Masters Business Admin degree from Harvard Business School and undergraduate degree from Harvard College.
-
- Ramona Sequeira
- Ramona Sequeira currently works at Edwards Lifesciences Corp., as Independent Director from 2020, Organon & Co., as Director from 2025, Harvey Mudd College, as Trustee, Takeda Pharmaceuticals U.S.A., Inc., as President-Global Portfolio from 2015, and Lake Forest Academy, as Trustee from 2017. Ms. Sequeira also formerly worked at Pharmaceutical Research & Manufacturers of America, as Chairman from 2022 to 2023, Eli Lilly & Co., as Associate Director-Neuroscience Marketing, The Executives Club of Chicago, as Director from 2017 to 2019, The Association of the British Pharmaceutical Industry, as Director, and Innovation Development Institute, Inc., as Director from 2017 to 2020. Ms. Sequeira received her undergraduate degree from the University of Toronto and Masters Business Admin degree from McMaster University.
-